I n the current issue of American Journal of Lifestyle Medicine, Dr Lapp 1 reviews the literature related to vitamin D and a number of health outcomes and concludes that "insufficient data exist to support reliable assessment and supplementation guidelines for most subpopulations." Undeniably, there is a substantial body of evidence that vitamin D inadequacy is associated with a number of adverse health effects. Many scientists and health professionals are advocating increasing vitamin D status, as reflected by 25(OH)D concentrations, above 30 ng/mL to maintain normal parathyroid hormone levels. 2 This can be accomplished either through increased exposure to ultraviolet radiation or by vitamin D supplements (ie, >2000 IU/d). 2 Although this might be appropriate, the long-term effects of these exposures for extended periods remain largely unknown.
Although numerous studies have not observed any adverse effects of higher vitamin D status, a few have. Historically, the main health risks associated with excessive vitamin D are linked with abnormal plasma calcium concentrations. Excessive vitamin D is recognized to cause hypercalcemia by increasing intestinal calcium absorption or by increasing mobilization of bone calcium. Although hypercalcemia is uncommon with intakes less than 10 000 IU/d, 3 knowledge of non-calcium-related adverse events is limited. At least some evidence suggests that high vitamin D status may be associated with increased risk of some cancers. In a large case control study of prostate cancer in Finland and Norway, both low (<7.6 ng/mL) and high (>32 ng/mL) 25(OH)D concentrations were reported to be associated with an increased incidence of prostate cancer (50% and 70%, respectively) compared with individuals with serum 25(OH)D concentrations between 16 and 24 ng/mL. 4 A direct relationship between higher vitamin D status and the development of esophageal carcinoma also has been observed in Chinese men. 5 Interestingly, all the participants, including those in the highest quintile, were vitamin D deficient (<20 ng/mL 25(OH)D). In a study in Finnish smokers, Stolzenberg-Solomon et al 6 associated higher baseline 25(OH)D (>26.2 ng/mL) with a 3-fold increased risk of pancreatic cancer compared to individuals with the lowest baseline status (<12.8 ng/mL). Overall, these studies suggest there may be an optimum status and that values below or above may increase risk of certain types of cancer.
Adverse events associated with high vitamin D status other than cancer also have been observed. Recent data from large epidemiologic studies, including the Third National Health and Nutrition Examination Survey (NHANES III) and the Framingham Heart Study, suggest that a "U-shaped curve" relationship exists with all-cause mortality and the incidence of cardiovascular disease because both low and high 25(OH)D concentrations elevated risk. 7, 8 In the NHANES III study, higher mortality risk was observed in participants with 25(OH)D above 49 ng/mL. In the Framingham study, the lowest cardiovascular disease risks were found in participants with baseline 25(OH)D levels of 20 to 25 ng/mL but increased with both lower and higher values, 8 thus suggesting that increased cardiovascular risk occurred at levels below 30 ng/mL. Furthermore, the optimal 25(OH)D levels for protection against cardiovascular disease and certain types of cancer may differ from those for bone metabolism or normal parathyroid hormone physiology. It should also be emphasized again that although few The relationship between dietary vitamin D intake and 25(OH)D concentration is diffi cult to evaluate.
studies have shown adverse effects of higher vitamin D status, many do not. Regardless, it remains prudent to be cautious in case there are circumstances where ill consequences will surface. The relationship between dietary vitamin D intake and 25(OH)D concentration is difficult to evaluate. At least part of the heterogeneity between studies appears to relate to the assay used. 9 In addition, elevations in serum 25(OH)D concentrations due to supplementation are inversely related to baseline 25(OH) D concentrations. For example, in a study of 7564 postmenopausal women with osteoporosis from 25 countries on 5 continents, supplements of 400 to 600 IU per day led to increases of serum 25(OH)D of 23.2 ± 12.8 ng/mL when baseline levels were <10 ng/mL, increases of only 15.8 ± 10.2 ng/mL when baseline levels were 10 to 20 ng/mL, and increases of 5.4 ± 11.8 ng/mL when baseline levels were higher than 20 ng/mL. 10 Even for those individuals with the same baseline serum 25(OH)D concentration, the dose response appears to decrease with increasing dose. 11 The best advice may be to proceed with caution. There is a wide range of intakes between the current adequate intake (200-600 IU/d depending on age) and the current tolerable upper intake level (2000 IU/d), the maximum daily intake unlikely to cause adverse health effects, established by the Food and Nutrition Board at the Institute of Medicine. 12 Intakes within this range are currently the best estimates of vitamin D intakes that should be sufficient to maintain bone health and normal calcium metabolism in healthy individuals and avoid potential adverse health effects. 12 It should be noted that the Institute of Medicine (IOM) has convened an ad hoc expert committee to undertake a study to assess current relevant data and update as appropriate the Dietary Reference Intakes (DRI) for vitamin D and calcium. The review will consider vitamin D in relation to the reduction in risk of cancer and other chronic diseases as well as the evidence related to vitamin D and bone health. It will also incorporate a systematic evidence-based review of the literature and an assessment of potential indicators of adequacy and of excess intake. Indicators for adequacy and excess will be selected based on the strength and quality of the evidence and the demonstrated public health significance, taking into consideration sources of uncertainty in the evidence. 13 This IOM review comes as a response to a wealth of new information that had not been considered previously. 14 Once the recommendations of this committee are available, they will represent the best available data related to vitamin D intake and are intended to serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. We all eagerly await a decision about what are appropriate intakes of vitamin D for the public. Regardless, greater knowledge of nutrition and the biological consequences of vitamin D will help identify if there are vulnerable populations. AJLM
